Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06045338 · ClinicalTrials.gov registry record · NA
Mind Body Intervention for Long COVID-19
A NA study of Long COVID and Post Acute Sequelae of COVID-19, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT06045338: Recruiting NA study of Long COVID and Post Acute Sequelae of COVID-19, sponsored by Beth Israel Deaconess Medical Center.
NCT06045338 is a NA study of Long COVID and Post Acute Sequelae of COVID-19 that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 180 participants, below the 2,185-participant average among 50 other Long COVID trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06045338, a NA study of Long COVID and Post Acute Sequelae of COVID-19, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine if a mind-body intervention can help people suffering from symptoms associated with Long COVID. The study is a randomized trial examining the effectiveness of a mind body intervention in reducing somatic symptoms from Long COVID in participants as compared to usual care and an active control (second mind body intervention). The investigators will secondarily investigate whether the intervention alleviates individual somatic complaints and improves daily functioning, relative to usual care and the active control
Primary Outcome
Survey questions pertain to pain, the gastrointestinal system, fatigue, dizziness, and cardiovascular complaints. Range of 0-32, with higher scores indicating higher levels of discomfort.
Conditions Studied
Interventions
- BEHAVIORAL Mind Body Intervention #1
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2023-11-09 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06045338 shows while recruiting
NCT06045338 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 2,185-participant average among 50 other Long COVID trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Long COVID appearing as the primary indexed condition, and to 1 intervention - of which Mind Body Intervention #1 is the first listed.
NCT06045338 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06045338 about?
NCT06045338 is a clinical study titled "Mind Body Intervention for Long COVID-19". The goal of this study is to determine if a mind-body intervention can help people suffering from symptoms associated with Long COVID. The study is a randomized trial examining the effectiveness of a mind body intervention in reducing somatic symptoms from Long COVID in participants as compared to u...
What is the current status of trial NCT06045338?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-11-09. Estimated completion is 2026-12.
What conditions does trial NCT06045338 study?
This clinical trial studies the following conditions: Long COVID, Post Acute Sequelae of COVID-19, COVID Long-Haul.
What interventions are being tested in trial NCT06045338?
The interventions under investigation include: Mind Body Intervention #1 (BEHAVIORAL).
Who is sponsoring clinical trial NCT06045338?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06045338 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Long COVID
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06045338's enrollment target sits among peer trials
180 19th of 50 higher than 31 of 50 other Long COVID trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Long COVID trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Water-based Activity to Enhance Recovery in Long COVID-19
RECRUITING · NA
-
Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
RECRUITING · NA
-
Long-Covid-19 Alleviation Through Learning Mindfulness Study
RECRUITING · NA
-
Sauna for Long Covid
RECRUITING · NA
-
Long COVID Brain Fog: Cognitive Rehabilitation Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI